PM

Pawan Miglani

Active Director Director DIN 01053031
DIN 01053031 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2005
Shareholding value •••• Premium profile

About Pawan Miglani

Data last updated:

Pawan Miglani is a Director at Feezo Chem. Formulation Private Limited (since 2005). The company operates in Pharma. Feezo Chem. Formulation Private Limited reported revenue of ₹3.72 Cr (FY 2025).

DIN 01053031
Primary Designation Director
Industry Pharma
First Appointment 28 Apr 2005
Oldest Company Age 21 yrs
Largest company Feezo Chem. Formulation Private Limited · ₹3.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20052005₹3.72 Cr (FY 2025)Active

Board colleagues of Pawan Miglani

Directorship timeline

Open interactive timeline →
Feezo Chem. Formulation Private Limited
Premium access

Shareholding and investment profile for Pawan Miglani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Miglani

Pawan Miglani currently holds 1 directorship: Feezo Chem. Formulation Private Limited (Director, since 28 Apr 2005, revenue ₹3.72 Cr (FY 2025)).

Pawan Miglani was first appointed on 28 Apr 2005 as Director at Feezo Chem. Formulation Private Limited.

The current boards of Pawan Miglani's companies include Geetika Miglani (Feezo Chem. Formulation Private Limited), Harsh Kumar (Feezo Chem. Formulation Private Limited), Karan Miglani (Feezo Chem. Formulation Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available